BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 17622242)

  • 1. A novel cell-penetrating peptide, M918, for efficient delivery of proteins and peptide nucleic acids.
    El-Andaloussi S; Johansson HJ; Holm T; Langel U
    Mol Ther; 2007 Oct; 15(10):1820-6. PubMed ID: 17622242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of splice correction by cell-penetrating peptide nucleic acids.
    El-Andaloussi S; Johansson HJ; Lundberg P; Langel U
    J Gene Med; 2006 Oct; 8(10):1262-73. PubMed ID: 16900561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct uptake routes of cell-penetrating peptide conjugates.
    Lundin P; Johansson H; Guterstam P; Holm T; Hansen M; Langel U; EL Andaloussi S
    Bioconjug Chem; 2008 Dec; 19(12):2535-42. PubMed ID: 19012426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficient splicing correction in the absence of endosomolytic agents.
    Abes S; Moulton HM; Clair P; Prevot P; Youngblood DS; Wu RP; Iversen PL; Lebleu B
    J Control Release; 2006 Dec; 116(3):304-13. PubMed ID: 17097177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural requirements for cellular uptake and antisense activity of peptide nucleic acids conjugated with various peptides.
    Wolf Y; Pritz S; Abes S; Bienert M; Lebleu B; Oehlke J
    Biochemistry; 2006 Dec; 45(50):14944-54. PubMed ID: 17154532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activatable cell penetrating peptide-peptide nucleic acid conjugate via reduction of azobenzene PEG chains.
    Lee SH; Moroz E; Castagner B; Leroux JC
    J Am Chem Soc; 2014 Sep; 136(37):12868-71. PubMed ID: 25185512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of cell-penetrating peptides (CPPs) as vehicles for intracellular delivery of antisense peptide nucleic acid (PNA).
    Bendifallah N; Rasmussen FW; Zachar V; Ebbesen P; Nielsen PE; Koppelhus U
    Bioconjug Chem; 2006; 17(3):750-8. PubMed ID: 16704214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced cellular delivery of cell-penetrating peptide-peptide nucleic acid conjugates by photochemical internalization.
    Shiraishi T; Nielsen PE
    Methods Mol Biol; 2011; 683():391-7. PubMed ID: 21053145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved cellular uptake of antisense peptide nucleic acids by conjugation to a cell-penetrating peptide and a lipid domain.
    Shiraishi T; Nielsen PE
    Methods Mol Biol; 2011; 751():209-21. PubMed ID: 21674333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. M918: A Novel Cell Penetrating Peptide for Effective Delivery of HIV-1 Nef and Hsp20-Nef Proteins into Eukaryotic Cell Lines.
    Rostami B; Irani S; Bolhassani A; Cohan RA
    Curr HIV Res; 2018; 16(4):280-287. PubMed ID: 30520377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic molecular evolution of hybrid cell penetrating peptides.
    Kauffman WB; Guha S; Wimley WC
    Nat Commun; 2018 Jul; 9(1):2568. PubMed ID: 29967329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides.
    Nakase I; Akita H; Kogure K; Gräslund A; Langel U; Harashima H; Futaki S
    Acc Chem Res; 2012 Jul; 45(7):1132-9. PubMed ID: 22208383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of cellular internalization pathways for CPP-mediated oligonucleotide delivery.
    Guterstam P; Andaloussi SE; Langel U
    Methods Mol Biol; 2011; 683():219-30. PubMed ID: 21053133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient splicing correction by PNA conjugation to an R6-Penetratin delivery peptide.
    Abes S; Turner JJ; Ivanova GD; Owen D; Williams D; Arzumanov A; Clair P; Gait MJ; Lebleu B
    Nucleic Acids Res; 2007; 35(13):4495-502. PubMed ID: 17584792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of novel protein-derived arginine-rich cell-penetrating peptides.
    Gautam A; Sharma M; Vir P; Chaudhary K; Kapoor P; Kumar R; Nath SK; Raghava GP
    Eur J Pharm Biopharm; 2015 Jan; 89():93-106. PubMed ID: 25459448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the delivery efficacy and internalization route of cell-penetrating peptides.
    El Andaloussi S; Guterstam P; Langel U
    Nat Protoc; 2007; 2(8):2043-7. PubMed ID: 17703217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular internalization kinetics of (luciferin-)cell-penetrating peptide conjugates.
    Eiríksdóttir E; Mäger I; Lehto T; El Andaloussi S; Langel U
    Bioconjug Chem; 2010 Sep; 21(9):1662-72. PubMed ID: 20684543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoplex and peptide-based strategies for the delivery of steric-block oligonucleotides.
    Resina S; Abes S; Turner JJ; Prevot P; Travo A; Clair P; Gait MJ; Thierry AR; Lebleu B
    Int J Pharm; 2007 Nov; 344(1-2):96-102. PubMed ID: 17600642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the uptake kinetics and internalization mechanisms of cell-penetrating peptides using a quenched fluorescence assay.
    Mäger I; Eiríksdóttir E; Langel K; El Andaloussi S; Langel U
    Biochim Biophys Acta; 2010 Mar; 1798(3):338-43. PubMed ID: 19909725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell penetration: scope and limitations by the application of cell-penetrating peptides.
    Reissmann S
    J Pept Sci; 2014 Oct; 20(10):760-84. PubMed ID: 25112216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.